Suppr超能文献

用艰难梭菌毒素A的无毒结合结构域经鼻内免疫诱导的局部和全身中和抗体反应。

Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile.

作者信息

Ward S J, Douce G, Dougan G, Wren B W

机构信息

Microbial Pathogenicity Research Group, Department of Microbiology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, West Smithfield, London ECIA 7BE, United Kingdom.

出版信息

Infect Immun. 1999 Oct;67(10):5124-32. doi: 10.1128/IAI.67.10.5124-5132.1999.

Abstract

Fourteen of the 38 C-terminal repeats from Clostridium difficile toxin A (14CDTA) were cloned and expressed either with an N-terminal polyhistidine tag (14CDTA-HIS) or fused to the nontoxic binding domain from tetanus toxin (14CDTA-TETC). The recombinant proteins were successfully purified by bovine thyroglobulin affinity chromatography. Both C. difficile toxin A fusion proteins bound to known toxin A ligands present on the surface of rabbit erythrocytes. Intranasal immunization of BALB/c mice with three separate 10-microg doses of 14CDTA-HIS or -TETC generated significant levels of anti-toxin A serum antibodies compared to control animals. The coadministration of the mucosal adjuvant heat labile toxin (LT) from Escherichia coli (1 microg) significantly increased the anti-toxin A response in the serum and at the mucosal surface. Importantly, the local and systemic antibodies generated neutralized toxin A cytotoxicity. Impressive systemic and mucosal anti-toxin A responses were also seen following coadministration of 14CDTA-TETC with LTR72, an LT derivative with reduced toxicity which shows potential as a mucosal adjuvant for humans.

摘要

艰难梭菌毒素A的38个C端重复序列中的14个(14CDTA)被克隆并表达,其要么带有N端多聚组氨酸标签(14CDTA-HIS),要么与破伤风毒素的无毒结合域融合(14CDTA-TETC)。重组蛋白通过牛甲状腺球蛋白亲和层析成功纯化。两种艰难梭菌毒素A融合蛋白均与兔红细胞表面存在的已知毒素A配体结合。与对照动物相比,用三个单独的10微克剂量的14CDTA-HIS或-TETC对BALB/c小鼠进行鼻内免疫产生了显著水平的抗毒素A血清抗体。同时给予来自大肠杆菌的黏膜佐剂热不稳定毒素(LT,1微克)可显著增强血清和黏膜表面的抗毒素A反应。重要的是,产生的局部和全身抗体中和了毒素A的细胞毒性。在将14CDTA-TETC与LTR72(一种毒性降低的LT衍生物,显示出作为人类黏膜佐剂的潜力)同时给药后,也观察到了令人印象深刻的全身和黏膜抗毒素A反应。

相似文献

5
Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.
Infect Immun. 2017 Mar 23;85(4). doi: 10.1128/IAI.01060-16. Print 2017 Apr.

引用本文的文献

1
Major pathogenic in human and progress toward the clostridial vaccines.
Iran J Basic Med Sci. 2022 Sep;25(9):1059-1068. doi: 10.22038/IJBMS.2022.65518.14417.
2
Frontiers in antibiotic alternatives for infection.
World J Gastroenterol. 2021 Nov 14;27(42):7210-7232. doi: 10.3748/wjg.v27.i42.7210.
3
Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
PLoS One. 2015 Aug 13;10(8):e0135045. doi: 10.1371/journal.pone.0135045. eCollection 2015.
5
The host immune response to Clostridium difficile infection.
Ther Adv Infect Dis. 2013 Feb;1(1):19-35. doi: 10.1177/2049936112472173.
6
Antibodies for treatment of Clostridium difficile infection.
Clin Vaccine Immunol. 2014 Jul;21(7):913-23. doi: 10.1128/CVI.00116-14. Epub 2014 Apr 30.
7
Vaccines against Clostridium difficile.
Hum Vaccin Immunother. 2014;10(6):1466-77. doi: 10.4161/hv.28428. Epub 2014 Mar 17.
8
Vaccination against Clostridium difficile using toxin fragments: Observations and analysis in animal models.
Gut Microbes. 2014 Mar-Apr;5(2):225-32. doi: 10.4161/gmic.27712. Epub 2014 Jan 22.
9
Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.
Vaccine. 2014 Feb 3;32(6):700-5. doi: 10.1016/j.vaccine.2013.11.099. Epub 2013 Dec 14.
10
Protective efficacy induced by recombinant Clostridium difficile toxin fragments.
Infect Immun. 2013 Aug;81(8):2851-60. doi: 10.1128/IAI.01341-12. Epub 2013 May 28.

本文引用的文献

3
Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli.
Vaccine. 1998 Jul;16(11-12):1065-73. doi: 10.1016/s0264-410x(98)80100-x.
4
Treatment of Clostridium difficile infection.
J Antimicrob Chemother. 1998 May;41 Suppl C:41-6. doi: 10.1093/jac/41.suppl_3.41.
5
Vancomycin-resistant enterococci.
Clin Infect Dis. 1998 May;26(5):1196-9. doi: 10.1086/520283.
7
Clostridium difficile toxin A binding to human intestinal epithelial cells.
J Med Microbiol. 1997 Nov;46(11):953-8. doi: 10.1099/00222615-46-11-953.
8
Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins.
Infect Immun. 1997 Oct;65(10):4288-98. doi: 10.1128/iai.65.10.4288-4298.1997.
9
Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.
Infect Immun. 1997 Jul;65(7):2821-8. doi: 10.1128/iai.65.7.2821-2828.1997.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验